Trust Company of Vermont’s Teladoc Health TDOC Stock Holding History

Trust Company of Vermont’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-100	Closed	-$918	–	1113
2024 Q3	$918	Hold	100	–	–	﹤0.01%	994
2024 Q2	$978	Hold	100	–	–	﹤0.01%	835
2024 Q1	$1.51K	Buy	+100	New	+$1.81K	﹤0.01%	794
2023 Q4	–	Sell	-100	Closed	-$1.86K	–	886
2023 Q3	$1.86K	Hold	100	–	–	﹤0.01%	757
2023 Q2	$2.53K	Hold	100	–	–	﹤0.01%	764
2023 Q1	$2.59K	Hold	100	–	–	﹤0.01%	803
2022 Q4	$2.37K	Hold	100	–	–	﹤0.01%	804
2022 Q3	$3K	Hold	100	–	–	﹤0.01%	898
2022 Q2	$3K	Buy	+100	New	+$4.25K	﹤0.01%	839
2022 Q1	–	Sell	-100	Closed	-$9K	–	687
2021 Q4	$9K	Buy	+100	New	+$12K	﹤0.01%	680
2021 Q3	–	Sell	-118	Closed	-$20K	–	660
2021 Q2	$20K	Sell	118 -9,535	-99%	-$1.54M	﹤0.01%	557
2021 Q1	$1.75M	Buy	9,653 +9,520	+7,158%	+$2.21M	0.13%	138
2020 Q4	$27K	Buy	133 +24	+22%	+$4.88K	﹤0.01%	513
2020 Q3	$24K	Hold	109	–	–	﹤0.01%	508
2020 Q2	$21K	Sell	109 -16	-13%	-$2.8K	﹤0.01%	533
2020 Q1	$20K	Buy	125 +16	+15%	+$1.86K	﹤0.01%	568
2019 Q4	$9K	Buy	109 +9	+9%	+$685	﹤0.01%	725
2019 Q3	$7K	Hold	100	–	–	﹤0.01%	791
2019 Q2	$7K	Hold	100	–	–	﹤0.01%	796
2019 Q1	$6K	Buy	+100	New	+$6.11K	﹤0.01%	776

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Trust Company of Vermont's TDOC Position: Q4 2024 in Review

Trust Company of Vermont sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 100 shares — an estimated $918 sold.

Trust Company of Vermont first reported a position in TDOC in Q1 2019 and held it in 20 quarters. The position peaked at $1.75M in Q1 2021. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

Trust Company of Vermont reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
Trust Company of Vermont sold 100 Teladoc Health shares in Q4 2024, an estimated $918.
Trust Company of Vermont first reported a position in Teladoc Health in Q1 2019 and held it in 20 quarters.
Trust Company of Vermont's Teladoc Health position peaked at $1.75M in Q1 2021.
381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Trust Company of Vermont's 13F filing for Q4 2024, filed 15 Jan 2025.